This trial is testing whether a certain type of injection is safe and effective for treating hip pain caused by arthritis.
1 Primary · 11 Secondary · Reporting Duration: For a period of 2 years following last injection
Awards & Highlights
2 Treatment Groups
1 of 2
1 of 2
24 Total Participants · 2 Treatment Groups
Primary Treatment: Autologous Adipose Derived Mesenchymal Stromal Cells · No Placebo Group · Phase 1
Who is running the clinical trial?
Age 18 - 65 · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
How old are they?
|18 - 65||100.0%|
What site did they apply to?
|Mayo Clinic in Rochester||100.0%|
What portion of applicants met pre-screening criteria?
Frequently Asked Questions
How many participants are currently enrolling in this clinical exploration?
"Affirmative. Information published on clinicaltrials.gov attests that this medical research is now looking for participants - it was first launched on the 5th of November 2018 and last updated on December 2nd 2022. 24 volunteers need to be recruited from one trial centre." - Anonymous Online Contributor
Are recruitment efforts underway to include participants in this research?
"Affirmative. According to clinicaltrials.gov, this trial is actively enrolling participants at present and was initially posted on the 5th of November 2018 before being updated most recently on 2nd December 2022. A total of 24 patients need to be recruited from one site in particular." - Anonymous Online Contributor
Are individuals who are 25 years or older eligible for participation in this trial?
"This study is onboarding participants of legal age and under 65 years old." - Anonymous Online Contributor
What criteria must be satisfied in order to enroll in this research program?
"This clinical trial, which is recruiting approximately 24 patients, requires all participants to have osteoarthritis of the hip and be aged 18-65." - Anonymous Online Contributor
Is Autologous Adipose Derived Mesenchymal Stromal Cells a secure option for individuals?
"Autologous Adipose Derived Mesenchymal Stromal Cells have been assigned a safety rating of 1 due to the fact that this is still an early phase trial, with restricted evidence pointing toward its efficacy and security." - Anonymous Online Contributor